GAMH
ONC

Greenwoods Asset Management (HK)’s BeOne Medicines Ltd ONC Stock Holding History

Greenwoods Asset Management (HK)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,502
Closed -$3.75M – 37
2025
Q2 		$3.75M Buy
15,502
+6,173
+66% +$1.51M 0.13% 24
2025
Q1 		$2.54M Sell
9,329
-21,329
-70% -$4.99M 0.08% 28
2024
Q4 		$5.66M Hold
30,658
– – 0.18% 30
2024
Q3 		$6.88M Buy
+30,658
New +$5.52M 0.22% 26

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Greenwoods Asset Management (HK)'s ONC Position: Q3 2025 in Review

Greenwoods Asset Management (HK) sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 15,502 shares — an estimated $3.75M sold.

Greenwoods Asset Management (HK) first reported a position in ONC in Q3 2024 and held it in 4 quarters. The position peaked at $6.88M in Q3 2024. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • Greenwoods Asset Management (HK) reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • Greenwoods Asset Management (HK) sold 15,502 BeOne Medicines Ltd shares in Q3 2025, an estimated $3.75M.
  • Greenwoods Asset Management (HK) first reported a position in BeOne Medicines Ltd in Q3 2024 and held it in 4 quarters.
  • Greenwoods Asset Management (HK)'s BeOne Medicines Ltd position peaked at $6.88M in Q3 2024.
  • 266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Greenwoods Asset Management (HK)'s 13F filing for Q3 2025, filed 10 Nov 2025.